<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A ubiquitous herpesvirus that establishes life-long <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, the Epstein-Barr virus (EBV) has yielded little insight into how a single agent in general accord with its host can produce diverse pathologies ranging from <z:e sem="disease" ids="C0206186" disease_type="Neoplastic Process" abbrv="">oral hairy leukoplakia</z:e> to nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, from <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> to <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Its pathogenesis is further confounded by the less than total association of virus with histologically similar <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In other <z:mp ids='MP_0001799'>viral</z:mp> systems, defective (interfering) <z:mp ids='MP_0001799'>viral</z:mp> genomes are known to modulate outcome of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, with either ameliorating or intensifying effects on disease processes initiated by prototype strains </plain></SENT>
<SENT sid="3" pm="."><plain>To ascertain whether defective EBV genomes are present in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, we examined paraffin-embedded tissue from 56 HD cases whose EBV status was first determined by cytohybridization for nonpolyadenylated EBV <z:chebi fb="40" ids="33697">RNAs</z:chebi> (EBERs) </plain></SENT>
<SENT sid="4" pm="."><plain>Using both standard polymerase chain reaction (PCR) and PCR in situ hybridization, we successfully amplified sequences that span abnormally juxtaposed BamHI W and Z fragments characteristic of defective <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> (het) EBV DNA from 10 of 32 (31%) EBER-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Of 24 EBER-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, 8 yielded PCR products indicating presence of het EBV DNA </plain></SENT>
<SENT sid="6" pm="."><plain>Two of these contained defective EBV in the apparent absence of the prototype virus </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 42 tumors analyzed for defective EBV by both PCR techniques, there was concordance of results in 38 (90%) </plain></SENT>
<SENT sid="8" pm="."><plain>Detection of defective EBV genomes with the potential to disrupt <z:mp ids='MP_0001799'>viral</z:mp> gene regulation suggests one mechanism for pathogenic diversity that may also account for loss of prototypic EBV from individual <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
</text></document>